Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
657 A combination treatment of bone marrow-derived CD141+dendritic cells and PD1/PD-L1 inhibitors for effective immunotherapy for solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.